178 related articles for article (PubMed ID: 22820754)
21. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.
Rey JW; Noetel A; Hardt A; Canbay A; Alakus H; Zur Hausen A; Dienes HP; Drebber U; Odenthal M
World J Gastroenterol; 2010 Dec; 16(46):5830-7. PubMed ID: 21155004
[TBL] [Abstract][Full Text] [Related]
22. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].
Xu J; Xin YN; Lü WH; Lin ZH; Zhang DD; Zhang M; Dong QJ; Jiang XJ; Xuan SY
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):619-23. PubMed ID: 24119744
[TBL] [Abstract][Full Text] [Related]
23. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.
Zain SM; Mohamed R; Mahadeva S; Cheah PL; Rampal S; Basu RC; Mohamed Z
Hum Genet; 2012 Jul; 131(7):1145-52. PubMed ID: 22258181
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.
Li YY
World J Gastroenterol; 2012 Dec; 18(45):6546-51. PubMed ID: 23236228
[TBL] [Abstract][Full Text] [Related]
25. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
26. Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease.
Sookoian S; Castaño G; Gemma C; Gianotti TF; Pirola CJ
World J Gastroenterol; 2007 Aug; 13(31):4242-8. PubMed ID: 17696255
[TBL] [Abstract][Full Text] [Related]
27. Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver disease.
Barbieri M; Esposito A; Angellotti E; Rizzo MR; Marfella R; Paolisso G
PLoS One; 2013; 8(8):e71391. PubMed ID: 23977033
[TBL] [Abstract][Full Text] [Related]
28. Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis.
Sahebkar A
DNA Cell Biol; 2013 Apr; 32(4):188-98. PubMed ID: 23448101
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD].
Cao MB; Yang YX; Dong L
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):773-7. PubMed ID: 21059296
[TBL] [Abstract][Full Text] [Related]
30. Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.
Penyige A; Poliska S; Csanky E; Scholtz B; Dezso B; Schmelczer I; Kilty I; Takacs L; Nagy L
BMC Med Genet; 2010 Nov; 11():152. PubMed ID: 21044285
[TBL] [Abstract][Full Text] [Related]
31. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
[TBL] [Abstract][Full Text] [Related]
32. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort.
Poliska S; Penyige A; Lakatos PL; ; Papp M; Palatka K; Lakatos L; Molnar T; Nagy L
Inflamm Bowel Dis; 2012 Mar; 18(3):472-9. PubMed ID: 21710534
[TBL] [Abstract][Full Text] [Related]
33. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor.
Sanghera DK; Demirci FY; Been L; Ortega L; Ralhan S; Wander GS; Mehra NK; Singh J; Aston CE; Mulvihill JJ; Kamboh IM
Metabolism; 2010 Apr; 59(4):492-501. PubMed ID: 19846176
[TBL] [Abstract][Full Text] [Related]
34. Association of the
Perez-Diaz-Del-Campo N; Abete I; Cantero I; Marin-Alejandre BA; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Riezu-Boj JI; Milagro FI; Tur JA; Martinez JA; Zulet MA
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32365683
[TBL] [Abstract][Full Text] [Related]
35. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.
Al-Serri A; Anstee QM; Valenti L; Nobili V; Leathart JB; Dongiovanni P; Patch J; Fracanzani A; Fargion S; Day CP; Daly AK
J Hepatol; 2012 Feb; 56(2):448-54. PubMed ID: 21756849
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis.
Liu Y; Wan W; Fang F; Guo L; Zhao Y; Zhang X; Huang F
J Clin Lab Anal; 2018 May; 32(4):e22340. PubMed ID: 29055064
[TBL] [Abstract][Full Text] [Related]
37. A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis.
Marangoni RG; Korman BD; Allanore Y; Dieude P; Armstrong LL; Rzhetskaya M; Hinchcliff M; Carns M; Podlusky S; Shah SJ; Ruiz B; Hachulla E; Tiev K; Cracowski JL; Varga J; Hayes MG
Arthritis Res Ther; 2015 May; 17(1):128. PubMed ID: 25986483
[TBL] [Abstract][Full Text] [Related]
38. PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets.
Chen H; Tan H; Wan J; Zeng Y; Wang J; Wang H; Lu X
Pharmacol Ther; 2023 May; 245():108391. PubMed ID: 36963510
[TBL] [Abstract][Full Text] [Related]
39. Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women.
Meirhaeghe A; Cottel D; Amouyel P; Dallongeville J
Diabetes; 2005 Oct; 54(10):3043-8. PubMed ID: 16186413
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis.
Cai W; Weng DH; Yan P; Lin YT; Dong ZH; Mailamuguli ; Yao H
Lipids Health Dis; 2019 Jan; 18(1):14. PubMed ID: 30646922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
